loadpatents
name:-0.021221876144409
name:-0.011746883392334
name:-0.00042581558227539
Nadin; Alan John Patent Filings

Nadin; Alan John

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nadin; Alan John.The latest application filed is for "pharmaceutical product comprising a muscarinic receptor antagonist and a beta-2-adrenoceptor agonist".

Company Profile
0.19.25
  • Nadin; Alan John - Harlow GB
  • Nadin; Alan John - Essex GB
  • Nadin; Alan John - Harlow Essex GB
  • Nadin; Alan John - Sawbridgeworth GB
  • Nadin; Alan John - Swabridgeworth GB
  • Nadin, Alan John - terlings Park Eastwick Road GB
  • Nadin; Alan John - Cambridge GB
  • Nadin, Alan John - Hartfordshire GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Thienopyrimidine derivatives as P13K inhibitors
Grant 8,293,735 - Hancox , et al. October 23, 2
2012-10-23
Thiazolopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase
Grant 8,168,633 - Hancox , et al. May 1, 2
2012-05-01
2-hydroxy-ethanesulfonate Salt
App 20110245292 - Nadin; Alan John
2011-10-06
Pharmaceutical Product Comprising A Muscarinic Receptor Antagonist And A Beta-2-adrenoceptor Agonist
App 20110245293 - Avitabile; Barbara G. ;   et al.
2011-10-06
Purine Derivatives Useful As P13 Kinase Inhibitors
App 20110230464 - Goldsmith; Paul ;   et al.
2011-09-22
Pharmaceutical Product Comprising A Muscarinic Receptor Antagonist And A Second Active Ingredient
App 20110207770 - Avitabile; Barbara G. ;   et al.
2011-08-25
Thiazolopyrimidines And Their Use As Inhibitors Of Phosphatidylinositol-3 Kinase
App 20110098270 - Hancox; Timothy Colin ;   et al.
2011-04-28
Thiazolopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase
Grant 7,893,060 - Hancox , et al. February 22, 2
2011-02-22
Thienopyrimidine Derivatives As P13k Inhibitors
App 20110021496 - Hancox; Timothy Colin ;   et al.
2011-01-27
Thiazolopyrimidines And Their Use As Inhibitors Of Phosphatidylinositol-3 Kinase
App 20100190769 - Hancox; Timothy Colin ;   et al.
2010-07-29
Heterocyclic Derivatives as M3 Muscarinic Receptors
App 20100056565 - Avitabile; Barbara Giuseppina ;   et al.
2010-03-04
Gamma-secretase inhibitors
Grant 7,655,675 - Nadin , et al. February 2, 2
2010-02-02
Sulphones which modulate the action of gamma-secretase
Grant 7,598,386 - Castro Pineiro , et al. October 6, 2
2009-10-06
Sulphones which modulate the action of gamma secretase
Grant 7,595,344 - Castro Pineiro , et al. September 29, 2
2009-09-29
Sulphones which modulate the action of gamma secretase
App 20090131419 - Castro Pineiro; Jose Luis ;   et al.
2009-05-21
Cyclohexyl sulphones as gamma-secretase inhibitors
Grant 7,410,964 - Dinnell , et al. August 12, 2
2008-08-12
Sulphonamido-substituted bridged bicycloalkyl derivatives
Grant 7,365,196 - Belanger , et al. April 29, 2
2008-04-29
Cyclic sulfonamides for inhibition of gamma-secretase
Grant 7,342,009 - Dinnell , et al. March 11, 2
2008-03-11
Cyclic sulfonamides for inhibition of gamma-secretase
App 20080045515 - Dinnell; Kevin ;   et al.
2008-02-21
Novel cyclohexyl sulphones
App 20080045533 - Churcher; Ian ;   et al.
2008-02-21
Cyclohexyl sulphones
Grant 7,304,094 - Churcher , et al. December 4, 2
2007-12-04
Sulphones which modulate the action of gammasecretase
App 20070213329 - Castro Pineiro; Jose Luis ;   et al.
2007-09-13
Benzodiazepine derivatives as APP modulators
Grant 7,105,509 - Castro Pineiro , et al. September 12, 2
2006-09-12
Novel cyclohexyl sulphones
App 20060041020 - Churcher; Ian ;   et al.
2006-02-23
Benzodiazepine derivatives as inhibitors of gamma secretase
Grant 6,995,155 - Churcher , et al. February 7, 2
2006-02-07
Gamma-secretase inhibitors
Grant 6,984,626 - Nadin , et al. January 10, 2
2006-01-10
Cyclohexyl sulphones
Grant 6,984,663 - Churcher , et al. January 10, 2
2006-01-10
Cyclohexyl sulphones as gamma-secretase inhibitors
Grant 6,890,956 - Churcher , et al. May 10, 2
2005-05-10
Gamma-secretase inhibitors
App 20050075320 - Nadin, Alan John ;   et al.
2005-04-07
Cyclic sulfonamides for inhibition of gamma-secretase
App 20040230054 - Dinnell, Kevin ;   et al.
2004-11-18
Gamma-secretase inhibitors
Grant 6,756,511 - Castro Pineiro , et al. June 29, 2
2004-06-29
Cyclohexyl sulphones as gamma-secretase inhibitors
App 20040121995 - Churcher, Ian ;   et al.
2004-06-24
Investigational compounds
Grant 6,753,410 - Nadin , et al. June 22, 2
2004-06-22
Sulphones which modulate the action of gamma secretase
App 20040116404 - Pineiro, Jose Luis Castro ;   et al.
2004-06-17
Benzodiazepine derivatives as app modulators
App 20040082572 - Pineiro, Jose Luis Castro ;   et al.
2004-04-29
Sulphonamido-substituted bridged bicycloalkyl derivatives
App 20040029862 - Belanger, Patrice Charles ;   et al.
2004-02-12
Benzodiazepine derivatives as inhibitors of gamma secretase
App 20040024203 - Churcher, Ian ;   et al.
2004-02-05
Gamma secretase inhibitors
App 20030114387 - Castro Pineiro, Jose Luis ;   et al.
2003-06-19
Novel cyclohexyl sulphones
App 20030114496 - Churcher, Ian ;   et al.
2003-06-19
Gamma-secretase inhibitors
App 20030100512 - Nadin, Alan John ;   et al.
2003-05-29
Substituted 1H-pyridinyl-2-ones as GABAA alpha 2/3 ligands
Grant 6,352,994 - Collins , et al. March 5, 2
2002-03-05
Investigational compounds
App 20020013276 - Nadin, Alan John ;   et al.
2002-01-31
Substituted 1H-pyridinyl-2-ones as GABAA alpha 2/3 ligands
App 20010018438 - Collins, Ian James ;   et al.
2001-08-30
Substituted 1H-pyridinyl-2-ones as GABAA-.alpha. 2/3 ligands
Grant 6,200,982 - Collins , et al. March 13, 2
2001-03-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed